Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients

Eloisa Arbustini, Giampaolo Merlini, Antonello Gavazzi, Maurizia Grasso, Marta Diegoli, Roberta Fasani, Vittorio Bellotti, Gabriella Marinone, Patrizia Morbini, Barbara Dal Bello, Carlo Campana, Victor J. Ferrans

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The objective of this study was to investigate the spectrum of morphologic features in myocardial biopsy specimens from patients with cardiac immunocyte-derived (AL) amyloidosis. Cardiac involvement is the most important predictor of survival in AL amyloidosis. Myocardial biopsy remains the method of choice for diagnosing cardiac amyloidosis when noninvasive studies give equivocal results. Histologic, immunohistochemical, ultrastructural, and morphometric studies were made on myocardial biopsy specimens from 11 patients in whom the diagnosis of AL amyloidosis was based on the demonstration of a monoclonal immunoglobulinopathy and of amyloid deposits in tissues. Histopathologic study showed amyloid in 10 of the 11 biopsies. In one biopsy (Congo red negative), the diagnosis was made by ultrastructural identification of amyloid fibrils. In all patients, the deposits formed perimyocytic layers that measured up to 18 μm in thickness. These layers formed along the basement membranes, which were partially preserved in 5 patients and unrecognizable in 6. Interstitial nodular deposits were also present in 5 patients. Immunohistochemical studies for the characterization of the proteins in the amyloid deposits were diagnostic in 1 patient and confirmatory in 10. Nodular deposits, thick perimyocytic layers of amyloid and small myocyte diameters were associated with shorter survival of the patients. Small-vessel involvement and myofilament loss occurred in all patients. In conclusion, myocardial biopsy serves to (1) establish the diagnosis of cardiac amyloidosis; (2) characterize immunohistochemically the proteins in the amyloid fibrils and (3) assess the degree of myocyte damage and atrophy.

Original languageEnglish
Pages (from-to)528-536
Number of pages9
JournalAmerican Heart Journal
Volume130
Issue number3 PART 1
DOIs
Publication statusPublished - 1995

Fingerprint

Amyloidosis
Biopsy
Amyloid
Amyloid Plaques
Muscle Cells
Congo Red
Survival
Myofibrils
Basement Membrane
Atrophy
Proteins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac immunocyte-derived (AL) amyloidosis : An endomyocardial biopsy study in 11 patients. / Arbustini, Eloisa; Merlini, Giampaolo; Gavazzi, Antonello; Grasso, Maurizia; Diegoli, Marta; Fasani, Roberta; Bellotti, Vittorio; Marinone, Gabriella; Morbini, Patrizia; Dal Bello, Barbara; Campana, Carlo; Ferrans, Victor J.

In: American Heart Journal, Vol. 130, No. 3 PART 1, 1995, p. 528-536.

Research output: Contribution to journalArticle

Arbustini, E, Merlini, G, Gavazzi, A, Grasso, M, Diegoli, M, Fasani, R, Bellotti, V, Marinone, G, Morbini, P, Dal Bello, B, Campana, C & Ferrans, VJ 1995, 'Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients', American Heart Journal, vol. 130, no. 3 PART 1, pp. 528-536. https://doi.org/10.1016/0002-8703(95)90362-3
Arbustini, Eloisa ; Merlini, Giampaolo ; Gavazzi, Antonello ; Grasso, Maurizia ; Diegoli, Marta ; Fasani, Roberta ; Bellotti, Vittorio ; Marinone, Gabriella ; Morbini, Patrizia ; Dal Bello, Barbara ; Campana, Carlo ; Ferrans, Victor J. / Cardiac immunocyte-derived (AL) amyloidosis : An endomyocardial biopsy study in 11 patients. In: American Heart Journal. 1995 ; Vol. 130, No. 3 PART 1. pp. 528-536.
@article{344f29b47f9c4522a90f1979df935c25,
title = "Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients",
abstract = "The objective of this study was to investigate the spectrum of morphologic features in myocardial biopsy specimens from patients with cardiac immunocyte-derived (AL) amyloidosis. Cardiac involvement is the most important predictor of survival in AL amyloidosis. Myocardial biopsy remains the method of choice for diagnosing cardiac amyloidosis when noninvasive studies give equivocal results. Histologic, immunohistochemical, ultrastructural, and morphometric studies were made on myocardial biopsy specimens from 11 patients in whom the diagnosis of AL amyloidosis was based on the demonstration of a monoclonal immunoglobulinopathy and of amyloid deposits in tissues. Histopathologic study showed amyloid in 10 of the 11 biopsies. In one biopsy (Congo red negative), the diagnosis was made by ultrastructural identification of amyloid fibrils. In all patients, the deposits formed perimyocytic layers that measured up to 18 μm in thickness. These layers formed along the basement membranes, which were partially preserved in 5 patients and unrecognizable in 6. Interstitial nodular deposits were also present in 5 patients. Immunohistochemical studies for the characterization of the proteins in the amyloid deposits were diagnostic in 1 patient and confirmatory in 10. Nodular deposits, thick perimyocytic layers of amyloid and small myocyte diameters were associated with shorter survival of the patients. Small-vessel involvement and myofilament loss occurred in all patients. In conclusion, myocardial biopsy serves to (1) establish the diagnosis of cardiac amyloidosis; (2) characterize immunohistochemically the proteins in the amyloid fibrils and (3) assess the degree of myocyte damage and atrophy.",
author = "Eloisa Arbustini and Giampaolo Merlini and Antonello Gavazzi and Maurizia Grasso and Marta Diegoli and Roberta Fasani and Vittorio Bellotti and Gabriella Marinone and Patrizia Morbini and {Dal Bello}, Barbara and Carlo Campana and Ferrans, {Victor J.}",
year = "1995",
doi = "10.1016/0002-8703(95)90362-3",
language = "English",
volume = "130",
pages = "528--536",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3 PART 1",

}

TY - JOUR

T1 - Cardiac immunocyte-derived (AL) amyloidosis

T2 - An endomyocardial biopsy study in 11 patients

AU - Arbustini, Eloisa

AU - Merlini, Giampaolo

AU - Gavazzi, Antonello

AU - Grasso, Maurizia

AU - Diegoli, Marta

AU - Fasani, Roberta

AU - Bellotti, Vittorio

AU - Marinone, Gabriella

AU - Morbini, Patrizia

AU - Dal Bello, Barbara

AU - Campana, Carlo

AU - Ferrans, Victor J.

PY - 1995

Y1 - 1995

N2 - The objective of this study was to investigate the spectrum of morphologic features in myocardial biopsy specimens from patients with cardiac immunocyte-derived (AL) amyloidosis. Cardiac involvement is the most important predictor of survival in AL amyloidosis. Myocardial biopsy remains the method of choice for diagnosing cardiac amyloidosis when noninvasive studies give equivocal results. Histologic, immunohistochemical, ultrastructural, and morphometric studies were made on myocardial biopsy specimens from 11 patients in whom the diagnosis of AL amyloidosis was based on the demonstration of a monoclonal immunoglobulinopathy and of amyloid deposits in tissues. Histopathologic study showed amyloid in 10 of the 11 biopsies. In one biopsy (Congo red negative), the diagnosis was made by ultrastructural identification of amyloid fibrils. In all patients, the deposits formed perimyocytic layers that measured up to 18 μm in thickness. These layers formed along the basement membranes, which were partially preserved in 5 patients and unrecognizable in 6. Interstitial nodular deposits were also present in 5 patients. Immunohistochemical studies for the characterization of the proteins in the amyloid deposits were diagnostic in 1 patient and confirmatory in 10. Nodular deposits, thick perimyocytic layers of amyloid and small myocyte diameters were associated with shorter survival of the patients. Small-vessel involvement and myofilament loss occurred in all patients. In conclusion, myocardial biopsy serves to (1) establish the diagnosis of cardiac amyloidosis; (2) characterize immunohistochemically the proteins in the amyloid fibrils and (3) assess the degree of myocyte damage and atrophy.

AB - The objective of this study was to investigate the spectrum of morphologic features in myocardial biopsy specimens from patients with cardiac immunocyte-derived (AL) amyloidosis. Cardiac involvement is the most important predictor of survival in AL amyloidosis. Myocardial biopsy remains the method of choice for diagnosing cardiac amyloidosis when noninvasive studies give equivocal results. Histologic, immunohistochemical, ultrastructural, and morphometric studies were made on myocardial biopsy specimens from 11 patients in whom the diagnosis of AL amyloidosis was based on the demonstration of a monoclonal immunoglobulinopathy and of amyloid deposits in tissues. Histopathologic study showed amyloid in 10 of the 11 biopsies. In one biopsy (Congo red negative), the diagnosis was made by ultrastructural identification of amyloid fibrils. In all patients, the deposits formed perimyocytic layers that measured up to 18 μm in thickness. These layers formed along the basement membranes, which were partially preserved in 5 patients and unrecognizable in 6. Interstitial nodular deposits were also present in 5 patients. Immunohistochemical studies for the characterization of the proteins in the amyloid deposits were diagnostic in 1 patient and confirmatory in 10. Nodular deposits, thick perimyocytic layers of amyloid and small myocyte diameters were associated with shorter survival of the patients. Small-vessel involvement and myofilament loss occurred in all patients. In conclusion, myocardial biopsy serves to (1) establish the diagnosis of cardiac amyloidosis; (2) characterize immunohistochemically the proteins in the amyloid fibrils and (3) assess the degree of myocyte damage and atrophy.

UR - http://www.scopus.com/inward/record.url?scp=0029084779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029084779&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(95)90362-3

DO - 10.1016/0002-8703(95)90362-3

M3 - Article

C2 - 7661071

AN - SCOPUS:0029084779

VL - 130

SP - 528

EP - 536

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3 PART 1

ER -